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Background: Left ventricular (LV) dyssynchrony is associated with increased risk of all-cause mortality in patients
with end-stage renal disease. Our aim was to determine the associations of LV dynamic dyssynchrony with
peritoneal solute clearance in continuous ambulatory peritoneal dialysis (CAPD) patients. Our primary objective was
to determine the association between dynamic LV dyssynchrony and CAPD clearance at 2 years. Secondary
objectives were to identify the factors influencing dynamic dyssynchrony, and to examine the association between
dialysis adequacy and echocardiography-assessed LV outcomes.
Methods: Fifty CAPD patients and 13 healthy volunteers underwent three-dimensional (3D) dobutamine stress
echocardiography (DSE). The main endpoint was systolic dyssynchrony index (SDI). Secondary endpoints, including
NT-proBNP, troponin I, Kt/V, and biochemical parameters, were measured before stress echocardiography, and Kt/V
was measured again 2 years later. All values are expressed as medians and interquartile ranges (IQR).
Results: NT-proBNP (3872 [808–11779] vs. 4.99 [4.99–36.83] pg/mL, P < 0.001), and log NT-proBNP (3.587
[2.896–4.071] vs. 0.698 [0.698–1.540], P < 0.001) levels were significantly higher in the CAPD group than in the
control group. Real-time 3D DSE showed that the systolic dyssynchrony index was significantly different between
the two groups at the peak dobutamine stage (1.11% [0.76–1.64%] vs. 0.66% [0.50–1.02%], P = 0.004), but not at
resting (1.30% [0.89–1.74%] vs. 1.22 % [0.72–1.68%], P = 0.358).The subgroup of patients in the CAPD group with
greater improvements in dialysis adequacy had lower baseline dynamic SDI and more favorable echocardiographic
findings at 2 years. Dialysis adequacy decreased significantly at 2 year in patients with higher, but not in those with
lower dynamic SDI at baseline. In multivariate linear regression analysis, log NT-proBNP and SDI at the peak
dobutamine dose were significantly associated with Kt/V and weekly creatinine clearance at 2 years, while log
NT-proBNP was significant associated with SDI at the peak dobutamine stage. Female CAPD patients group had
more pronounced dynamic LV dyssynchrony compared with male patients.
Conclusions: Dynamic systolic dyssynchrony was strongly associated with future dialysis adequacy in CAPD
patients. Log NT-proBNP was the important predictor of dynamic dyssynchrony. Our study confirmed the concept
that cardiac dysfunction has an impact on dialysis adequacy.
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Solutes are transported from peritoneal capillaries to the
dialysate by diffusion and convection processes. Diffu-
sion is the most important transport mechanism for low
molecular weights solutes [1]. Recent studies have dem-
onstrated that transperitoneal clearance of small solutes
is limited by the rate of blood flow during peritoneal
dialysis [2]. The local renin–angiotensin–aldosterone
system (RAAS), which regulates cardiac hemodynamic
status and hypertension, plays an important role in the
fibrotic process [3].
Therefore, we hypothesized that cardiac dysfunction is
associated with small solute clearance in continuous am-
bulatory peritoneal dialysis (CAPD) patients.
Left ventricular (LV) compliance is an important
determinant of LV function and can be affected by a var-
iety of cardiovascular conditions. Diastolic dysfunction is
also associated with altered LV compliance [4]. Transtho-
racic three-dimensional echocardiography (3DE) confirmed
the feasibility of noninvasive estimation of the end-diastolic
pressure–volume relationship. 3DE was also able to differ-
entiate normal from abnormal LV compliance, which may
be difficult or impossible to do using conventional 2DE [5].
N-terminal prohormone of brain natriuretic peptide
(NT-proBNP) levels are correlated with LV wall stress,
sphericity index (SI), and the extent of myocardial dam-
age in patients with coronary artery disease (CAD), and
with volume overload in heart failure. NT-proBNP is
also an independent predictor of mortality in patients
with ESRD [6-8]. However, no studies have examined
whether NT-ProBNP can serve as a surrogate marker
for dynamic LV dyssynchrony.
From this context, the main objective of this study
was to investigate the association between LV dynamic
dyssynchrony and CAPD clearance 2 years later. Our
secondary objectives were to identify which factors
influence dynamic dyssynchrony and to determine the as-




Fifty uremic subjects on CAPD and 13 healthy volun-
teers were recruited from Changhua Christian Hospital,
Changhua, Taiwan, between 2008 and 2011. All of the
subjects were aged > 18 years and had normal sinus
rhythm. None of the subjects in the control group were
taking any medications. Subjects with acute coronary
syndrome, a history of myocardial infarction, acute heart
failure, congenital heart disease, severe valvular heart
disease, or severe uncontrolled hypertension (systolic
blood pressure [SBP] ≥ 210 mmHg or diastolic blood
pressure [DBP] ≥ 110 mmHg) were excluded. Subjectswith recent (< 3 months) peritonitis, other technique
failure, or recent hospitalization were also excluded.
All CAPD patients received 2 L of 5% glucose pe-
ritoneal dialysate (DianealW; Baxter, Singapore) during
transthoracic 3DE. The calculated peritoneal creatinine
clearance rate was normalized to 1.73 m2 of the body
surface area, and residual function was also taken into
account. Membrane transport status was analyzed using
a standard 4-h peritoneal equilibration test (PET). Dialy-
sis adequacy was calculated as Kt/V, where K = dialyzer
clearance of urea, t = dialysis time, and V = volume
distribution of urea.
The protocol was approved by Institutional Review Board
and the Ethics Committee of the Changhua Christian
Hospital, Taiwan. All enrolled subjects provided written in-
formed consent.
Dobutamine stress echocardiography (DSE)
Subjects underwent a standard dobutamine stress proto-
col, under continuous electrocardiography monitoring,
with infusions of 5, 10, 20, 30, and 40 μg/kg/min
dobutamine for 3 min at each stage. Heart rate and BP
were recorded at baseline, during each stage, and during
recovery (3 min after termination of infusion). Endpoints
for study termination were extensive new wall motion
abnormalities, attainment of the target heart rate (85%
of the maximal heart rate predicted for age), or comple-
tion of the protocol. Images were acquired at baseline,
during the final minute of each stage, and during recov-
ery. All images were acquired by the same cardiologist.
Real-time (RT)3DE
RT3DE images were obtained with an IE33 xMATRIX
echocardiography system (Philips Medical Systems,
Andover, MA) and an X3-1 transducer (2–4 MHz) using
secondary harmonic imaging. RT3DE images were ac-
quired from the apical window immediately after the ac-
quisition of 2DE images at each stage using another IE33
machine. Full-volume LV datasets were obtained for
offline analysis using a QLab system (Philip Medical Sys-
tems). LV datasets were divided into 16 segments, ex-
cluding the apex, as recommended by the American
Society of Echocadiography [9].
We used the dyssynchrony index, as previously described
by Kapetanakis et al [10]. The systolic dyssynchrony index
(SDI) was defined as the standard deviation of the time-
to-minimum systolic volume of 16 LV segments expressed
as a percentage of the R–R duration.
2DE
All 2DE parameters were measured using techniques
recommended by the American Society of Echocadiography
[9]. Systolic wall stress before dobutamine stress echocardi-
ography (DSE) was calculated according to the formula of
Table 1 Subject characteristics
Control group CAPD group P
n 13 50
Age, y 43.0 (32.0–52.0) 37.0 (35.0–44.3) 0.189
Male/female (n) 7/6 28/22 0.193
BSA (kg/m2) 1.71 (1.52–1.80) 1.68 (1.43–1.95) 0.609
Height (cm) 161.0 (155.5–167.5) 164.0 (153.0–168.3) 0.474
Weight (kg) 62.0 (52.0–72.3) 64.0 (47.5–79.0) 0.878
NT-proBNP (pg/mL) 4.99 (4.99–36.83) 3872 (808–11779) <0.001
Log NT-proBNP 0.698 (0.698–1.540) 3.587 (2.896–4.071) <0.001
SDI at baseline (%) 1.22 (0.72–1.68) 1.30 (0.89–1.74) 0.358
SDI at peak DSE (%) 0.66 (0.50–1.02) 1.11 (0.76–1.64) 0.004
SWS (mmHg) 40.5 (29.6–48.6) 61.7 (43.11–100.0) 0.001
Values are medians (interquartile range). BSA, body surface area; CAPD,
continuous ambulatory peritoneal dialysis; NT-proBNP, N-terminal pro-B-type
natriuretic peptide; SWS, systolic wall stress.
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using the biplane area–length method using 4- and 3-
chamber views [4].
Measurement of NT-proBNP and troponin I levels
Fasting (≥8 h) venous blood samples (4 mL) were
obtained before starting DSE. NT-proBNP was mea-
sured using an immunoassay (ECLIA; Roche Diagnostics
GmbH, Mannheim, Germany), and troponin I was mea-
sured using a chemiluminescent immunoassay (Access
AccuTnI assay; Beckman Coulter Inc., Brea, CA). NT-
proBNP levels were logarithmically transformed before
statistical analyses because the values were not normally
distributed.
Statistical analysis
All statistical procedures were performed using SPSS
software version 15.0 (SPSS Inc., Chicago, IL). All values
are expressed as medians (interquartile range, IQR)
Intergroup differences were determined using the
Mann–Whitney test and P values < 0.05 were consid-
ered to be statistically significant. Intragroup differences
(i.e., baseline vs. 2 years) were evaluated using the
Mann–Whitney test and Wilcoxon test. Spearman’s ρ
correlation and multivariate linear regression analyses
were used to determine the associations between echo-
cardiographic parameters and dialysis adequacy. Parame-
ters showing significant correlations in univariate
analyses and those with clinical relevance were then in-
cluded in stepwise multiple linear regression analysis.
Intraobserver and interobserver variability
Intraobserver variability was determined by repeating
the offline 3DE measurements of SDI at 2 weeks after
baseline in all subjects. Interobserver variability was
determined by comparison of all offline measurements
by two cardiologists who were blinded to each other’s in-
terpretations. Variability values were calculated as the
absolute difference between the corresponding measure-
ments in terms of the mean percentage.
Results
Subject characteristics
Table 1 summarizes the characteristics of CAPD patients
and the healthy volunteers. Both groups were matched
for BMI, age, and sex. NT-proBNP (3872 [808–11779]
vs.4.99 [4.99–36.83] pg/mL, P < 0.001), log NT-proBNP
(3.587 [2.896–4.071] vs. 0.698 [0.698–1.540] P < 0.001),
and systolic wall stress (61.7 [43.11–100.0] vs. 40.5
[29.6–48.6] mmHg, P = 0.001) values were significantly
higher in the CAPD group than control group. RT3DE
showed evidence of dynamic systolic dyssynchrony in
the CAPD group. SDI was significantly different betweenthe two groups, but only at the peak dobutamine dose
(1.11% [0.76–1.64%] vs. 0.66% [0.50–1.02%], P = 0.004).
Evaluation of SDI at the peak stage of DSE and 2-year
Kt/V in CAPD patients
One subject who underwent kidney transplantation and
one subject who switched to hemodialysis were excluded
from the follow-up study. The other 48 subjects in the
CAPD group underwent follow-up 2DE and resting 3DE
2 years after the original examinations. Positive values
for 2-year Kt/V – baseline Kt/V (ΔKt/V) indicated better
clearance function. Patients with a positive ΔKt/V value
had lower values of the LV mass index (MI), LV end-
diastolic volume (EDV) index, and LV end-systolic vol-
ume (ESV) index, as well as lower SDI at the peak stage
of DSE, as compared with patients with a negative ΔKt/
V value (Table 2). The median SDI in the CAPD group
at the peak dobutamine dose was 1.1%. Using this as a
reference value, CAPD patients were divided into two
subgroups according to SDI at the peak dobutamine
dose as having high (i.e., >1.1%) or low (≤1.1%) dynamic
SDI. The data are shown in Table 3. Dialysis adequacy at
2 years had decreased significantly from baseline in the
high SDI subgroup, but not in the low SDI subgroup.
We found no significant difference in troponin I concen-
trations between patients with low or high SDI (0.025
[0.09–0.05] vs. 0.035 [0.009–0.05] mg/mL, P = 0.247).
Factors influencing dialysis adequacy at 2 years
Multivariate linear regression analysis revealed that log
NT-proBNP, SDI at peak dobutamine dose, sex, and sys-
tolic wall stress were independently associated with Kt/V
at 2 years (Table 4). Multiple linear regression analysis
identified log NT-proBNP, SDI at peak dobutamine dose,
age are independent predictors of weekly creatinine
clearance at 2 years (Table 5).
Table 2 Kt/V and echocardiographic parameters at baseline and at 2 years
Patients with an improvement in Kt/V Patients with a worsening in Kt/V P
n 14 34
Baseline
LVM (g) 82.2 (77.6–91.3) 188.8 (107.8–201.9) <0.001
LVMI (g/m2) 61.8 (51.0–63.4) 95.3 (76.4–107.9) <0.001
LVIDd (mm) 40.0 (34–44) 56.0 (47–60) <0.001
LVIDs (mm) 25.0 (23.0–26.0) 39.0 (27.5–43.0) 0.004
LA (mm) 32.0 (25.0–39.0) 40.0 (33.5–45.0) 0.012
RV (mm) 19.0 (15.0–20.0) 22.0 (20.3–25.3) 0.002
IVS (mm) 9.0 (7.0–12.0) 12.0 (10.5–16.0) 0.002
LVPW (mm) 9.0 (8.0–9.0) 11.5 (8.8–13.0) 0.014
SWS 44.22 (33.87–63.26) 61.680 (52.00–100.02) 0.027
EDV index (ml/m2) 27.30 (24.14–39.10) 50.05 (44.70–56.30) <0.001
ESV index (ml/m2) 8.8 (4.93–14.51) 18.00 (12.38–22.50) <0.001
LA volume (ml) 34.6 (18.22–41.5) 68.0 (35.1–70.1) 0.002
LA volume index (ml/m2) 22.76 (13.70–28.83) 34.39 (25.78–38.10) 0.002
SDI at peak DSE (%) 0.71 (0.61–0.86) 1.51 (1.11–2.24) <0.001
SDI at baseline (%) 1.20 (0.95–1.57) 1.35 (0.78–3.13) 0.688
EF (%) 64.0 (62.9–82.0) 62.7 (57.6–74.7) 0.056
logNT-proBNP 2.96 (2.70–3.30) 3.9 (3.23–4.50) 0.002
NT-proBNP 904.0 (502.0–1996.0) 7494.0 (2025.8–31357.0) 0.002
Kt/V 2.00 (1.96–2.06) 2.08 (1.79–2.33) 0.365
WCC 51.35 (44.93–79.83) 67.63 (61.13–79.4) 0.027
At 2 years
LVM (g) 101.51 (89.64–105.06) 208.07 (126.14–284.31) <0.001
LVMI (g/m2) 69.11 (67.40–70.49) 113.08 (85.29–143.59) <0.001
LVIDd (mm) 41.0 (37.0–44.0) 48.0 (46.3–60.0) <0.001
LVIDs (mm) 24.0 (18.0–26.0) 30.0 (27.0–47.0) <0.001
LA (mm) 37.0 (24.0–39.0) 44.5 (40.9–50.0) <0.001
RV (mm) 19.0 (18.0–25.0) 25.0 (23.5–26.3) 0.001
IVS (mm) 8.0 (7.0–12.0) 13.0 (11.8–16.0) <0.001
LVPW (mm) 9.0 (6.0–9.0) 12.0 (9.0–14.0) <0.001
EDV index (ml/m2) 34.68 (30.03–38.82) 64.92 (51.00–75.30) <0.001
ESV index (ml/m2) 11.3 (8.13–17.61) 23.6 (10.7–35.5) 0.056
LA volume (ml) 32.1 (22.6–51.0) 68.4 (45.8–83.3) <0.001
LA volume index (ml/m2) 22.3 (17.0–33.5) 42.1 (32.9–45.0) 0.002
EF (%) 70.9 (54.9–73.2) 68.1 (50.6–78.5) 0.840
Kt/V 2.34 (2.02–2.41) 1.81 (1.50–2.12) <0.001
WCC 54.65 (46.17–80.14) 60.22 (48.34–65.50) 0.482
Change in Kt/V was calculated at Kt/V at 2 years – baseline Kt/V; positive changes were classified as improvements and negative changes as worsening. Values are
medians (interquartile range). BSA, body surface area; IVSd, interventricular septum thickness (diastolic); LVPWd, left ventricular posterior wall thickness (diastolic);
LVIDd, LV internal diameter (diastolic); LVIDs, LV internal diameter (systolic); LVMI, LV mass index; LA, left atrium; RV, right ventricle; LVEDV, LV end-diastolic volume;
LVESV, LV end-systolic volume; LVEF, LV ejection fraction; SDI, systolic dyssynchrony index; NT-proBNP, N-terminal pro-B-type natriuretic peptide; WCC, weekly
creatinine clearance.
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Table 3 Change in dialysis adequacy indices change and
SDI at peak DSE
Group SDI ≤1.1% SDI >1.1%
n 23 25
Kt/V
Baseline 2.06 (2.00–2.08) 1.86 (1.79–2.26)
2 years 2.34 (2.04–2.38) 1.72 (1.50–2.09)
P 0.165 <0.001
WCC
Baseline 61.10 (51.35–69.99) 68.99 (61.14–79.4)
2 years 54.65 (51.38–78.93) 60.22 (39.25–63.13)
P 0.68 <0.001
Values are medians (interquartile range). P-values were determined using the
Wilcoxon two related samples test. DSE, dobutamine stress echocardiography;
SDI, systolic dyssynchrony index; WCC, weekly creatinine clearance.
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Multivariate linear regression analysis showed that log
NT-proBNP and sex were independently associated with
SDI at peak dobutamine dose (Table 6).
Intraobserver and interobserver variability
The interobserver variability for SDI was 6.3%, while
intraobserver variability was 5.7%.
Discussion
DSE is a useful tool for evaluating cardiovascular risk in
ESRD patients who are potential candidates for renal
transplantation [12]. It also provides a comprehensive
assessment of changes in echocardiographic parameters
during each stage by using novel 3D echocardiographic
tools [13]. 3D DSE is now widely considered as an alter-
native to exercise testing to accurately and reproducibly
assess dynamic LV dyssynchrony [14]. Here, we re-
port novel results showing that CAPD patients have
more obvious LV systolic dyssynchrony in response to
dobutamine stress, despite normal LVEF and similar
resting dyssynchrony index, compared with healthy indi-
viduals. The difference in stress-induced dyssynchronyTable 4 Multivariate regression analysis with Kt/V at 2 years









SDI, systolic dyssynchrony index; NT-proBNP, N-terminal pro-B-type natriuretic pepti
systolic wall stress.between CAPD patients and healthy controls is probably
caused by LV hypertrophy (LVH) in the former, as
CAPD patients are more likely to develop LVH. LVH is
associated with increased myocardial oxygen demand
and abnormal coronary flow, and may result in
subendocardial ischemia or regional dysfunction during
stress [15]. Differences in volume status may also be re-
sponsible for the difference, as volume overload is more
common in CAPD patients than in the normal popula-
tion [16]. Additionally, previous reports revealed that
volume status may modulate LV dyssynchrony [17,18].
Aljaroudi et al. reported that, among patients with
ESRD, the prevalence of all-cause mortality is higher in
patient with than in those without LV dyssynchrony
[19]. A greater degree of dyssynchrony increased the 2-
year mortality rate by 4–7-fold in patients free of high-
risk features such as depressed LVEF, wide QRS,
increased LV mass, or a large perfusion defect. Their
study highlights the importance of cardiac dyssynchrony
in terms of its detrimental effects on prognosis. We are
eager to known whether its detrimental effects on prog-
nosis are mediated by dialysis adequacy or cardiac
structure.
An earlier study revealed that cardiac structure and
function are influenced by uremic status and adequate
dialysis therapy in pediatric CAPD patients; however,
that was a cross-sectional study rather than a longitu-
dinal study [20]. It is unknown whether cardiac function
has an impact on long-term dialysis adequacy. So far,
there are no data showing which echocardiographic
parameters can predict long-term dialysis adequacy. In
our longitudinal study, we clearly showed that dynamic
dyssynchrony (SDI at peak DSE) and logNT-proBNP
were significantly associated with indices of dialysis ad-
equacy at 2 years (Kt/V and WCC; as shown in Tables 4
and 5). In patients with low dynamic SDI, the dialysis
adequacy indices did not change significantly. However,
in patients with high dynamic SDI, the dialysis adequacy
indices tended to deteriorate over time, as shown
in Table 3. A possible explanation for the dynamicas the dependent variable








de; SDI, systolic dyssynchrony index; LVMI, left ventricular mass index; SWS,
Table 5 Multivariate regression analysis with WCC at 2 years as the dependent variable
Predictors Regression coefficient Standard error Standardized coefficient P
Intercept −86.124 17.761 0.000
Sex −23.627 11.957 −0.780 0.055
Age 0.940 0.196 0.602 0.000
SDI at peak dose −4.265 1.374 −0.606 0.004
logNT-proBNP −0.154 0.044 −0.295 0.001
LVMI −0.082 0.117 −0.333 0.488
SWS −0.009 0.043 −0.023 0.827
R2=0.815
WCC, weekly creatinine clearance; SDI, systolic dyssynchrony index; NT-proBNP, N-terminal pro-B-type natriuretic peptide; SWS, systolic wall stress; LVMI, left
ventricular mass index.
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is as following. Stress-induced dyssynchrony may de-
crease the forward stroke volume, decreasing blood flow
to the peritoneal capillaries responsible for solute clear-
ance. This was observed in heart failure subjects with
preserved ejection fraction [21]. The clinical scenario is
very similar in CAPD patients who often have LV hyper-
trophy but preserved ejection fraction. Because we only
included non-ischemic patients in this study, we did not
observe a significant difference in troponin I concentra-
tions between patients with high or low SDI. Adequate
solute and fluid removal is the cornerstone of dialysis
therapy and both are important targets of dialysis ad-
equacy. Fluid overload is often seen in PD patients, and
may contribute to high cardiac mortality [22,23]. How-
ever, it is difficult to determine the volume status in
PD patients using routine clinical methods [24]. NT-
proBNP is synthesized in the LV in response to greater
ventricular work, and is a marker of myocardial damage
and fluid overload [6]. As shown in Table 6, log NT-
proBNP was the most important predictor of cardiac
dyssynchrony during the stress test, even after adjusting
for other traditional parameters. Log NT-proBNP wasTable 6 Multivariate regression analysis with SDI at peak DSE







EDV index 0.086 0
ESV index −0.147 0
SWS −0.012 0
R2=0.750
SDI, systolic dyssynchrony index; DSE, dobutamine stress echocardiography; EDV, en
wall stress ; NT-proBNP, N-terminal pro-B-type natriuretic peptide.also independently associated with PD adequacy, as
shown in Tables 4 and 5. Therefore, elevated NT-
proBNP levels may reflect fluid overload in CAPD
patients, and is easy to measure in clinical settings. As
indicated in Table 2, CAPD subset with a greater im-
provement in Kt/V change at 2 years showed less systolic
LV wall stress as compared with patients with poorer
improvements in Kt/V. Altered myocardial stress can re-
sult in the production of cytokines and reactive oxygen spe-
cies, which can stimulate myocyte apoptosis [25] and
extracellular matrix disruption [26], important triggers for
destructive LV dilatation and remodeling [27]. Progressive
LV dilatation and changes in chamber shape (i.e., increasing
sphericity) can further stretch myocytes and upregulate the
expression of stretch response proteins, which can induce
pathologic cardiomyocyte hypertrophy [28]. In the current
study, we found that patients with improvements in Kt/V
had favorable echocardiographic parameters, including a
lower LVMI, a smaller LV chamber, and a thinner LV wall,
as compared with patients with a worsening in Kt/V. Taken
together, our results suggest that higher dynamic LV
dyssynchrony could predict lower Kt/V and unfavorable
echocardiographic outcomes 2 years later.as the dependent variable










d-diastolic volume; ESV, end-systolic volume; EF, ejection fraction; SWS, systolic
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nounced dynamic LV dyssynchrony than males. This
finding is consistent with the findings reported by
Kuznetsova et al [29],. who reported that, in a study
population with LV diastolic dysfunction, females had
greater dyssynchrony compared with males. The differ-
ences in susceptibility between sexes could be related to
sex hormones, such as estrogen [30].
Some limitations should be discussed. For example,
the study sample size was relatively small and we only
examined systolic dyssynchrony; regression analysis
cannot address causality, only associations between two
factors; and other unrecorded/untested parameters may
influence the results.
Conclusions
Dynamic systolic dyssynchrony was strongly associated
with future dialysis adequacy in CAPD patients. Log
NT-proBNP was the important predictor of dynamic
dyssynchrony. Our study confirmed the concept that
cardiac dysfunction has an impact on dialysis adequacy.
Future studies should evaluate stress-related diastolic
dyssynchrony, and the associations in different study
populations, such as patients with stage III–V CKD.
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